Xinle Wu
Company: Sciwind Biosciences
Job title: Chief Scientific Officer & Head of Research
Seminars:
Panel Discussion: Navigating the Evolving NASH Landscape to Apprehend the Future of Combination Therapies & Optimize Treatment 2:30 pm
Deliberating the best approaches to position GLP-1s for different indications, mono therapy, and combination therapy How are we maximizing the use of injectables and oral medicines? Uniting towards a shared goal to advances towards efficacious NASH treatments through collaborative effortsRead more
day: Day 1 Seminar B Post-Lunch Tracks
Disentangling Cutting-Edge Insights in Combination Therapy for Obesity & NASH Treatment 12:30 pm
Combination of GLP-1 and other mechanism has potential to lead to better therapeutic profile GIP, Amylin and GDF15 demonstrated synergy with GLP-1R agonist Unravelling novel considerations for designing combination studiesRead more
day: Day 1 Seminar B Pre-Lunch Tracks